What's new

Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion under re-examination

Jun 3, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion under re-examination
Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion under re-examination
Read More

Tags:

Previous Article

Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commissio...

Next Article

Questions and answers on the refusal of the marketing authorisation for Atropine...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Betmiga, Mirabegron, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0085/2024

Opinion/decision on a Paediatric investigation plan (PI...

May 14, 2025  0

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Process for the electronic submission of medicinal prod...

Jun 2, 2025  0